C. Yoo

529P A phase Ib trial of belvarafenib in combination with cobimetinib in patients (pts) with RAS- or RAF- mutated (m) solid tumors: Updated safety data and indication-specific efficacy results

S. Shin, C. Ahn, Y. Kim, 2021, Annals of Oncology.

Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib

F. Piscaglia, A. Cucchetti, V. Sansone, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

Is There Pathological Uniformity between the Periphery and Center of a Gastrointestinal Stromal Tumor?

H. Lee, Kwan Hong Lee, J. Yoon, 2021, Journal of clinical medicine.

55P Final results from the NIFTY trial, a phase IIb, randomized, open-label study of liposomal Irinotecan (nal-IRI) plus fluorouracil (5-FU)/leucovorin (LV) in patients (pts) with previously treated metastatic biliary tract cancer (BTC)

G. Abou-Alfa, J. Lee, B. Ryoo, 2022, Annals of Oncology.

M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial.

M. Osada, M. Ikeda, D. Oh, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.